Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis Pharma, and LENZ Therapeutics, after getting FDA approval for its ...

Please provide your email address to receive an email when new articles are posted on . In a study, the most common complaint after presbyopia-correcting IOL implantation was blurry vision. IOL ...

If you are finding yourself holding restaurant menus at arm’s length or squinting at your phone, you are likely experiencing presbyopia. This natural, age-related condition affects nearly everyone ...

Credit: Tenpoint Therapeutics. Tenpoint Therapeutics launches Yuvezzi, a fixed-dose combination ophthalmic solution for presbyopia. Yuvezzi is supplied in single dose vials containing carbachol 27.5mg ...

The most common side effects were headache, impaired vision, and temporary eye pain or eye irritation. "The FDA approval of Yuvezzi represents a significant milestone for the millions of people in the ...

The gradual loss of near vision that is a natural part of aging can be addressed by glasses, contact lenses, or even surgical procedures. A presbyopia eye drop developed by Tenpoint Therapeutics now ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Yuvezzi is the first FDA-approved dual-agent eye drop for presbyopia, combining carbachol and brimonidine tartrate. Phase III trials showed Yuvezzi significantly improved near visual acuity without ...

Presbyopia is a progressive, age-related loss of the eye’s ability to focus on objects in the near distance. The most common symptom of presbyopia is blurry vision, but it may also cause eye strain ...

Eye redness was not a commonly reported side effect in clinical trials of YUVEZZI. In BRIO I and BRIO II the reports of adverse events of ocular hyperemia (eye redness) were low. 1,2 In BRIO II, the ...

Presbyopia is a decline in your vision when your eyes lose the ability to focus on things close to you. In spite of the big name, it isn't a disease. It's a natural part of the aging process, and it's ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...